Clinical Trials Directory

Trials / Completed

CompletedNCT05993130

Evaluation of Patients With Covid-19 Infection in Terms of Severity of Osteoprosis

Kayseri City (Education and Research) Hospital

Status
Completed
Phase
Study type
Observational
Enrollment
55 (actual)
Sponsor
Kayseri Education and Research Hospital · Other Government
Sex
Female
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

Osteoporosis is a condition characterized by decreased bone strength and an increased risk of fracture. Age, gender, body mass index, fragility fracture history, corticosteroid use, immobilization, smoking and alcohol use, endocrine pathologies besides inflammatory and infectious pathologies can also be effective in the development of osteoporosis. The aim of the study is to evaluate the effect of Covid-19 infection on the development of osteoporosis. In this study, bone mineral density (BMD) measurements of patients with Covid-19 infection were examined. For this, dual-energy x-ray absorptiometry (DEXA) measurement was used. A total of 55 patients were included in the study and data such as age, height, weight, comorbidities, drugs used, and treatment methods were recorded. Results showed that the time spent in the intensive care unit was associated with the femoral neck T score in DEXA measurements of patients with Covid-19 infection. The use of drugs such as alendronate, zolendronate, denosumab or teriparatide during the treatment process did not have a statistically significant effect on the lumbar and femur T scores.

Conditions

Interventions

TypeNameDescription
OTHERThe patients were not intervened. This is a retrospective studyThe patients were not intervened. This is a retrospective study

Timeline

Start date
2021-01-15
Primary completion
2022-12-15
Completion
2022-12-15
First posted
2023-08-15
Last updated
2023-08-15

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05993130. Inclusion in this directory is not an endorsement.